The Impact of Atopic Dermatitis on Quality of Life
Expert dermatologists review the impact of atopic dermatitis on quality of life for both the patient and their families.
Read More
An Overview of Atopic Dermatitis (AD)
Peter A. Lio, MD, provides an overview of the pathophysiology of atopic dermatitis (AD) and the comorbidities often associated with it.
Keeping Physicians Up to Date With AD Advances
Experts in dermatology share advice on helping fellow physicians stay apprised of the advances in AD and treat their patients more effectively.
Emerging Treatment Options in AD
Expert dermatologists consider ongoing trials and emerging treatment options for the management of AD.
Guidance for Topical Treatment Use Based on BSA in AD
Experts in dermatology share general guidance for use of topicals, switching from topical to systemic treatment, and when combination therapy is an option for patients with atopic dermatitis.
Monitoring AD Treatments in Various Age Groups
Omar Noor, MD, and Adelaide A. Hebert, MD, discuss monitoring requirements for various classes of treatments in atopic dermatitis, including topical vs systemic.
Treatment Options for Patients With Moderate Disease Over 10%-20% BSA
Peter A. Lio, MD, reviews treatment options for patients with moderate AD.
Treatment Goals in AD
Matthew Zirwas, MD, shares goals of therapy for a patient with AD.
Implications of Boxed Warnings of Topical JAK inhibitors
Expert dermatologists address the clinical implications of boxed warnings of topical treatments in AD.
Time to Response in AD
Matthew Zirwas, MD, and Omar Noor, MD, comment on their own experience of time to response with topical and systemic treatments of AD.
Durability of Response to Treatment in AD
Peter A. Lio, MD, discusses the durability of topical treatments in AD, including steroids, calcineurin inhibitors, and JAK inhibitors.
Efficacy Data for Topical Treatment of AD
Experts discuss long-term efficacy data for topical medications for the treatment of AD.
Patient With Limited Disease Activity in AD
Matthew Zirwas, MD, and Omar Noor, MD, review a patient scenario where AD disease activity is limited but in difficult to treat locations.
AD Treatment Options for Patients Moving Away from Long-Term Steroids
Peter A. Lio, MD, shares his approach to presenting treatment alternatives to patients who want to stop using long-term steroids for treatment of AD.
Challenges Faced by Non-Dermatologists When Using Steroids
Adelaide A. Hebert, MD, comments on the need for nondermatologist education on the basics of skin disease care.
Durability of Topical Steroid Use in AD
Expert dermatologists discuss the durability of long-term use of topical steroids for treatment of atopic dermatitis.
Patient on Long-Term Steroidal Use in AD
Adelaide A. Hebert, MD, reviews the use of long-term steroids for treatment of atopic dermatitis.
Factors Guiding Treatment Selection in AD
Experts in dermatology discuss which disease characteristics play the biggest role in influencing treatment choice or change of treatment from the perspective of a patient with atopic dermatitis.
Treatment Options and Targets in Atopic Dermatitis (AD)
A panel of expert dermatologists comments on newly approved and traditional treatment options, addressing how they target inflammation and the pathophysiology of atopic dermatitis (AD).
The Importance of Patient Education in Atopic Dermatitis Management
Experts in dermatology stress the importance of patient education in atopic dermatitis management and discuss their approaches to keeping patients up-to date.
Emerging Therapies and Future Directions for Pediatric Atopic Dermatitis
Raj Chovatiya, MD, PhD; Brittany G. Craiglow, MD; and Peter A. Lio, MD, provide insight into emerging therapies and future directions in the management of pediatric atopic dermatitis.
Evolution of Treatment Selection for Pediatric Atopic Dermatitis Management
Dr Peter A. Lio hypothesizes about the ability to induce remission in patients suffering from atopic dermatitis with the use of biologics and holistic treatment approaches.
Dupilumab Dosing Considerations for Pediatric Patient Populations
Dr Brittany G. Craiglow reviews dosing considerations and nuances for the use of dupilumab for atopic dermatitis in pediatric populations.
Recent Advances for Dupilumab Use in Pediatric Patients With Atopic Dermatitis
Experts in dermatology review the indications and evolution of the use of dupilumab in patients with atopic dermatitis, highlighting its recent approval for patients 6 months and older.
Efficacy and Safety of Upadacitinib for Atopic Dermatitis Treatment
Brittany G. Craiglow, MD, discusses the efficacy and safety of upadacitinib and describes her clinical experiences with this treatment.
Efficacy and Safety of Ruxolitinib for Atopic Dermatitis Treatment
Brittany G. Craiglow, MD, and Peter A. Lio, MD, provide insight into the efficacy and safety of currently available JAK inhibitors for the treatment of pediatric atopic dermatitis.
Overview of Systemic Treatment Indications for Pediatric Atopic Dermatitis
Raj Chovatiya, MD, PhD, highlights recent advances in pediatric atopic dermatitis treatments and discusses considerations regarding their use and indications.
Advice for Curating an Atopic Dermatitis Treatment Plan
Dr Peter A. Lio shares his advice for curating an atopic dermatitis treatment plan and explains the difference between rescue and maintenance treatments.
Nonpharmacological Approaches to Treat Pediatric Atopic Dermatitis
Dr Brittany G. Craiglow provides an overview of her approach to use of nonpharmacological agents in the treatment of her pediatric patients with atopic dermatitis.
Defining Treatment Success in Patients With Atopic Dermatitis
Raj Chovatiya, MD, PhD, and Brittany G. Craiglow, MD, share their opinions on how they assess and what they define as treatment success in their pediatric patients suffering from atopic dermatitis.